What to know about Ginkgo Bioworks Holdings Inc (DNA)’s sales and margins

Currently, Ginkgo Bioworks Holdings Inc [DNA] is trading at $1.41, up 8.46%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

On 1, February 2024, Bioluminescent Plants Are Now Even Brighter: Light Bio to Begin Selling Firefly Petunias to Consumers with USDA Approval. In a post published today on Yahoo Finance, Light Bio, an innovative synthetic biology startup, today announced that it is beginning to sell its groundbreaking bioluminescent petunias in the United States. With support from notable biotech leaders such as NFX and Ginkgo Bioworks (NYSE: DNA), Light Bio is reimagining the horticultural industry by introducing a new category of plants that emit an ethereal glow to enrich homes, gardens, and public spaces.

From an analyst’s perspective:

Ginkgo Bioworks Holdings Inc [NYSE: DNA] stock has seen the most recent analyst activity on November 14, 2023, when Raymond James downgraded its rating to a Mkt Perform and also revised its price target to $2.50 from $3.50.

This stock has fluctuated between a low of $1.12 and a high of $2.55 over the last 52 weeks. Ginkgo Bioworks Holdings Inc [NYSE: DNA] shares were valued at $1.41 at the most recent close of the market.

Analyzing the DNA fundamentals

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3333 points at the first support level, and at 1.2567 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4533, and for the 2nd resistance point, it is at 1.4967.

Ginkgo Bioworks Holdings Inc [DNA] reported earnings per share of -$0.16 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.09/share, meaning a difference of -$0.07 and a surprise factor of -77.80%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.09 per share as compared to estimates of -$0.08 per share, a difference of -$0.01 representing a surprise of -12.50%.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Ginkgo Bioworks Holdings Inc [NYSE:DNA] is 6.78.

Transactions by insiders

In the past 3 months, 0 insiders have purchased 0 shares, and 6 have sold 350,600 shares. Recent insider trading involved Dmytruk Mark E.,, that happened on Feb 02 when 39569.0 shares were sold., Kelly Jason R completed a deal on Jan 04 to sell 100000.0 shares. Meanwhile, Kelly Jason R sold 100000.0 shares on Jan 03.

Related Posts